Related Experiment Video
Updated: May 24, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Cholesterol level influences opioid signaling in cell models and analgesia in mice and humans
Hui Zheng1, Haibo Zou, Xiaopeng Liu
1Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China. zheng_hui@gibh.ac.cn
Abstract:
Cholesterol regulates the signaling of µ-opioid receptor in cell models, but it has not been demonstrated in mice or humans. Whether cholesterol regulates the signaling by mechanisms other than supporting the entirety of lipid raft microdomains is still unknown. By modulating cholesterol-enriched lipid raft microdomains and/or total cellular cholesterol contents in human embryonic kidney cells stably expressing µ-opioid receptor, we concluded that cholesterol stabilized opioid signaling both by supporting the lipid raft's entirety and by facilitating G protein coupling. Similar phenomena were observed in the primary rat hippocampal neurons. In addition, reducing the brain cholesterol level with simvastatin impaired the analgesic effect of opioids in mice, whereas the opioid analgesic effect was enhanced in mice fed a high-cholesterol diet. Furthermore, when the records of patients were analyzed, an inverse correlation between cholesterol levels and fentanyl doses used for anesthesia was identified, which suggested the mechanisms above could also be applicable to humans. Our results identified the interaction between opioids and cholesterol, which should be considered in clinics as a probable route for drug-drug interaction. Our studies also suggested that a low cholesterol level could lead to clinical issues, such as the observed impairment in opioid functions.
Insights
Cholesterol stabilizes opioid receptor signaling by supporting lipid rafts and G protein coupling. This interaction impacts opioid effectiveness in mice and humans, suggesting clinical relevance for drug interactions and cholesterol levels.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Cholesterol's role in µ-opioid receptor (MOR) signaling is established in cell models but unproven in vivo.
- The precise mechanisms by which cholesterol influences MOR signaling beyond lipid raft integrity remain unclear.
Purpose of the Study:
- To investigate cholesterol's regulation of MOR signaling in cellular and animal models.
- To elucidate the specific mechanisms of cholesterol's influence on MOR signaling.
- To assess the clinical relevance of the opioid-cholesterol interaction.
Main Methods:
- Modulation of cholesterol levels in human embryonic kidney cells expressing MOR.
- Assessment of MOR signaling in primary rat hippocampal neurons.
- Pharmacological studies in mice using simvastatin and high-cholesterol diets.
- Retrospective analysis of patient records correlating cholesterol levels and opioid doses.
Main Results:
- Cholesterol stabilizes MOR signaling by maintaining lipid raft structure and enhancing G protein coupling in cell and neuronal models.
- Reducing brain cholesterol with simvastatin impaired opioid analgesia in mice; high-cholesterol diets enhanced it.
- A significant inverse correlation was found between patient cholesterol levels and fentanyl dosage for anesthesia.
Conclusions:
- Cholesterol plays a dual role in stabilizing MOR signaling, impacting both lipid raft integrity and G protein coupling.
- The opioid-cholesterol interaction is relevant in vivo, affecting analgesic efficacy in mice and clinical opioid requirements in humans.
- Clinical consideration of cholesterol levels is crucial for understanding opioid drug-drug interactions and potential functional impairments.
More Related Videos
06:54A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice
Published on: November 15, 2024
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Cholesterol: Significance and Regulation
Considering cholesterol and...
Nociception